Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Friday, July 17, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Pharma
Pharma
Pharma
Takeda’s Zasocitinib Shows High Skin-Clearance Rates Across Hard-to-Treat Psoriasis Sites
Life Sciences Times
-
July 17, 2026
Pharma
Rectify Pharmaceuticals Names Constantine Chinoporos Executive Chairman
Life Sciences Times
-
July 16, 2026
Pharma
Keytruda Improves Progression-Free Survival in Phase 3 Endometrial Cancer Trial
Life Sciences Times
-
July 15, 2026
Pharma
Alkermes Reports Sustained Wakefulness Improvements With Alixorexton in Narcolepsy Study
Life Sciences Times
-
July 13, 2026
Pharma
EMD Serono Gets FDA Breakthrough Therapy Designation for Enpatoran in Lupus Patients
Life Sciences Times
-
July 8, 2026
Pharma
Vertex to Acquire Crinetics Pharmaceuticals in $10 Billion Deal
Life Sciences Times
-
July 7, 2026
0
Pharma
PharmaEssentia Receives Health Canada Approval for BESREMi for Polycythemia Vera
Life Sciences Times
-
July 6, 2026
0
Pharma
Vertex Wins FDA Approval to Expand CASGEVY Use to Children Ages 2 and Older
Life Sciences Times
-
July 2, 2026
0
Pharma
Hengrui’s Heng Yi Approved in China for Dry Eye Disease
Life Sciences Times
-
June 30, 2026
0
Pharma
Shionogi Partners With ALS Consortium to Expand Real-World Disease Research
Life Sciences Times
-
June 26, 2026
0
Pharma
PharmaEssentia Launches FDA-Approved BESREMi Pen for Polycythemia Vera
Life Sciences Times
-
June 26, 2026
0
Pharma
EU Approves Keytruda-Padcev Regimen for Muscle-Invasive Bladder Cancer
Life Sciences Times
-
June 24, 2026
0
Pharma
Definium Reports Positive Phase 3 Results for Depression Treatment DT120
Life Sciences Times
-
June 22, 2026
0
Pharma
Organon Completes Licensing Agreement for Sebela’s Hormone-Free IUD
Life Sciences Times
-
June 22, 2026
0
Pharma
Bionyra Pharma Launches With $165 Million to Advance Inflammatory Disease Pipeline
Life Sciences Times
-
June 22, 2026
0
Pharma
Alkermes Reports Positive Phase 2 Results for Alixorexton in Adults With Narcolepsy Type 2
Life Sciences Times
-
June 18, 2026
0
Pharma
Utebzi Approved in U.S. for Adults With Complicated Urinary Tract Infections
Life Sciences Times
-
June 18, 2026
0
1
2
3
...
96
Page 1 of 96
Most Read
Mirador Therapeutics Licenses Long-Acting Anti-C5a Antibody from Kira Pharmaceuticals
July 17, 2026
Bayer and Henry Ford Health Partner to Expand Patient Access to Clinical Trials
July 17, 2026
Inflammasome Therapeutics Reports Positive Phase 2 Results for K8 in Geographic Atrophy
July 17, 2026
Aqemia and Sanofi Expand AI-Driven Drug Discovery Collaboration
July 17, 2026